↓ Skip to main content

Cochrane Database of Systematic Reviews

Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer

Overview of attention for article published in Cochrane database of systematic reviews, August 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter
f1000
1 research highlight platform

Citations

dimensions_citation
89 Dimensions

Readers on

mendeley
84 Mendeley
citeulike
1 CiteULike
Title
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
Published in
Cochrane database of systematic reviews, August 2012
DOI 10.1002/14651858.cd005343.pub3
Pubmed ID
Authors

Jo Morrison, Krishnayan Haldar, Sean Kehoe, Theresa A Lawrie

Abstract

Epithelial ovarian cancer presents at an advanced stage in the majority of women. These women require surgery and chemotherapy for optimal treatment. Conventional treatment is to perform surgery first and then give chemotherapy. However, it is not yet clear whether there are any advantages to using chemotherapy before surgery.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Netherlands 1 1%
Unknown 82 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 18%
Other 12 14%
Student > Master 11 13%
Student > Ph. D. Student 10 12%
Student > Bachelor 9 11%
Other 17 20%
Unknown 10 12%
Readers by discipline Count As %
Medicine and Dentistry 50 60%
Nursing and Health Professions 8 10%
Agricultural and Biological Sciences 5 6%
Biochemistry, Genetics and Molecular Biology 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 3 4%
Unknown 12 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 October 2012.
All research outputs
#9,468,629
of 16,112,803 outputs
Outputs from Cochrane database of systematic reviews
#9,308
of 11,405 outputs
Outputs of similar age
#69,811
of 133,502 outputs
Outputs of similar age from Cochrane database of systematic reviews
#85
of 112 outputs
Altmetric has tracked 16,112,803 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,405 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.8. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 133,502 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 112 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.